0001104659-23-093893.txt : 20230821 0001104659-23-093893.hdr.sgml : 20230821 20230821154544 ACCESSION NUMBER: 0001104659-23-093893 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230821 DATE AS OF CHANGE: 20230821 EFFECTIVENESS DATE: 20230821 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Serimmune Inc. CENTRAL INDEX KEY: 0001693808 IRS NUMBER: 464761259 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-409629 FILM NUMBER: 231189032 BUSINESS ADDRESS: STREET 1: 917 N. PATTERSON AVE. CITY: SANTA BARBARA STATE: CA ZIP: 93111 BUSINESS PHONE: (805) 451-5083 MAIL ADDRESS: STREET 1: 917 N. PATTERSON AVE. CITY: SANTA BARBARA STATE: CA ZIP: 93111 D/A 1 primary_doc.xml X0708 D/A LIVE 0001693808 Serimmune Inc. 150 CASTILIAN DRIVE, SUITE 100 GOLETA CA CALIFORNIA 93117 (805) 650-5229 DELAWARE None None Corporation true Malek Faham 150 Castilian Drive, Suite 100 Goleta CA CALIFORNIA 93117 Executive Officer Director Bill Welch C/o Serimmune Inc. 150 Castilian Drive, Suite 100 Goleta CA CALIFORNIA 93117 Director Nicholas Naclerio C/o Serimmune Inc. 150 Castilian Drive, Suite 100 Goleta CA CALIFORNIA 93117 Director Kirstin Loomis 150 Castilian Drive, Suite 100 Goleta CA CALIFORNIA 93117 Director Biotechnology Decline to Disclose 06b true 0001104659-22-123637 2023-07-24 true true true Convertible Promissory Notes and the Equity Securities issuable upon conversion of such Notes false 0 15000000 10612176 4387824 false 2 0 0 0 false Serimmune Inc. /s/ Malek Faham Malek Faham Chief Executive Officer 2023-08-21